Inventor · disambiguated record
Peter Langecker
Also filed as: LANGECKER PETER · LANGECKER PETER J
3 granted patents·13 pending applications·6 citations·filing 1999–2022
55Inventor score
Files withLOS GATOS PHARMACEUTICALS INC3INTARCIA THERAPEUTICS INC2DURECT CORP1EPICENTRX INC1INTARICA THERAPEUTICS INC1
Top patents by PatentIndex Score
16 records- 0179US10064855B2Composite nanoparticles and uses thereofLOS GATOS PHARMACEUTICALS INC·Filed 2017·Granted Sep 4, 2018·6 cites·24 claims
- 0255US2011250297A1Treatment of Hyperproliferative Disorders Using Cardiac GlycosidesORONSKY BRYAN T·Filed 2009·Application pending·0 cites
- 0351US12433877B2Sustained release drug delivery systems and related methodsDURECT CORP·Filed 2022·Granted Oct 7, 2025·0 cites·20 claims
- 0450US2005228053A1Combination therapy for the treatment of estrogen-sensitive diseaseINTARCIA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 0549US2005130945A1Combination therapy for the treatment of estrogen-sensitive diseaseFiled 2004·Application pending·0 cites
- 0649US2005176691A1Combination therapy for the treatment of estrogen-sensitive diseaseFiled 2004·Application pending·0 cites
- 0748US10407437B2Camptothecin derivatives and uses thereofLOS GATOS PHARMACEUTICALS INC·Filed 2017·Granted Sep 10, 2019·0 cites·3 claims
- 0846US2005232862A1Combination therapy for the treatment of estrogen-sensitive drugsINTARCIA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 0946US2010104624A1Combination therapy using phosphodiesterase inhibitorsLANGECKER PETER·Filed 2009·Application pending·0 cites
- 1045US2018369232A1Composite Nanoparticles And Uses ThereofLOS GATOS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1144US2002119502A1Combination therapy for the treatment of estrogen-sensitive diseaseFiled 2001·Application pending·0 cites
- 1240US2016331771A1Treatment of Hyperproliferative Disorders Using Cardiac GlycosidesEPICENTRX INC·Filed 2016·Application pending·0 cites
- 1339US2007248572A1Method for treating diseases with omega interferonINTARICA THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1436US2003191162A13-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapySUGEN INC·Filed 2002·Application pending·0 cites
- 1532US2003143197A1Method for treating diseases with omega interferonFiled 2002·Application pending·0 cites
- 1627US2003073837A13-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapyFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Langecker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →